Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P090018/S042

Esteem

Envoy Medical Corporation · Decision date May 21, 2026

FDA DECISIONP090018/S042

What did the FDA approve?

FDA records P090018/S042 as a supplement to PMA P090018, with the supplement type “Real-Time Process”. The recorded decision is approval, dated May 21, 2026.

FDA approval order statement

Approval for a new laser reflector material used with Laser Doppler Vibrometer (LDV) measurements during the implantation procedure.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Ear, Nose, Throat
Decision date
May 21, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P090018/S042
Regulatory pathway
PMA supplement
Product code
OAF
Decision code
APPR
Decision date
May 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implant, hearing, active, middle ear, totally implanted.

Product code
OAF
FDA device class
3

For the original device and its historical approval scope, see PMA P090018. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P090018 · Original PMA

    ESTEEM TOTALLY IMPLANTABLE HEARING SYSTEM

  2. P090018/S042 received

    Application receipt date recorded by FDA.

  3. P090018/S042 · FDA decision

    Real-Time Process

Timeline entries are records held by MedtechLedger for P090018. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P090018

Product / regulatory recordCompanyPathwayDecision dateSource
Envoy Medical CorporationPMA approvalMar 17, 2010FDA
EsteemP090018/S043
Envoy Medical CorporationPMA supplementJun 3, 2026FDA
EsteemP090018/S044
Envoy Medical CorporationPMA supplementOct 15, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Envoy Medical Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
4875 White Bear Pkwy., White Bear Lake, MN, 55110

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records